These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 31030301

  • 21. Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding".
    Montgomery ET, van der Straten A, Stadler J, Hartmann M, Magazi B, Mathebula F, Laborde N, Soto-Torres L.
    AIDS Behav; 2015 May; 19(5):784-93. PubMed ID: 25416076
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Misreporting of Product Adherence in the MTN-003/VOICE Trial for HIV Prevention in Africa: Participants' Explanations for Dishonesty.
    Montgomery ET, Mensch B, Musara P, Hartmann M, Woeber K, Etima J, van der Straten A.
    AIDS Behav; 2017 Feb; 21(2):481-491. PubMed ID: 27858268
    [Abstract] [Full Text] [Related]

  • 25. Qualitative Perceptions of Dapivirine VR Adherence and Drug Level Feedback Following an Open-Label Extension Trial.
    Naidoo K, Mansoor LE, Katz AWK, Garcia M, Kemigisha D, Morar NS, Zimba CC, Chitukuta M, Reddy K, Soto-Torres L, Naidoo S, Montgomery ET.
    J Acquir Immune Defic Syndr; 2021 Apr 01; 86(4):e90-e96. PubMed ID: 33278181
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention.
    Reidy M, Gardiner E, Pretorius C, Glaubius R, Torjesen K, Kripke K.
    PLoS One; 2019 Apr 01; 14(6):e0218710. PubMed ID: 31242240
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study.
    Nel A, van Niekerk N, Van Baelen B, Malherbe M, Mans W, Carter A, Steytler J, van der Ryst E, Craig C, Louw C, Gwetu T, Mabude Z, Kotze P, Moraba R, Tempelman H, Gill K, Kusemererwa S, Bekker LG, Devlin B, Rosenberg Z, DREAM Study Team.
    Lancet HIV; 2021 Feb 01; 8(2):e77-e86. PubMed ID: 33539761
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study.
    Montgomery ET, Beksinska M, Mgodi N, Schwartz J, Weinrib R, Browne EN, Mphili N, Musara P, Jaggernath M, Ju S, Smit J, Chirenje ZM, Doncel GF, van der Straten A.
    J Int AIDS Soc; 2019 May 01; 22(5):e25283. PubMed ID: 31069957
    [Abstract] [Full Text] [Related]

  • 36. Acceptability of an extended duration vaginal ring for HIV prevention and interest in a multi-purpose ring.
    Stoner MCD, Browne EN, Gundacker HM, Hawley I, Chen BA, Hoesley C, Scheckter R, Piper J, Singh D, Song M, Liu A, van der Straten A.
    PLoS One; 2022 May 01; 17(2):e0263664. PubMed ID: 35192655
    [Abstract] [Full Text] [Related]

  • 37. Perspectives from Young South African and Zimbabwean Women on Attributes of Four (Placebo) Vaginal Microbicide Delivery Forms.
    Weinrib R, Browne EN, Shapley-Quinn MK, van der Straten A, Beksinska M, Mgodi N, Musara P, Mphili N, Schwartz JL, Ju S, Hanif H, Montgomery ET, Quatro Study Team.
    AIDS Behav; 2020 Feb 01; 24(2):637-647. PubMed ID: 31254190
    [Abstract] [Full Text] [Related]

  • 38. Acceptability of a Tenofovir Disoproxil Fumarate Vaginal Ring for HIV Prevention Among Women in New York City.
    Watnick D, Keller MJ, Stein K, Bauman LJ.
    AIDS Behav; 2018 Feb 01; 22(2):421-436. PubMed ID: 29147810
    [Abstract] [Full Text] [Related]

  • 39. Understanding women's motivations to participate in MTN-003/VOICE, a phase 2b HIV prevention trial with low adherence.
    Katz AWK, Mensch BS, Woeber K, Musara P, Etima J, van der Straten A.
    BMC Womens Health; 2019 Jan 25; 19(1):18. PubMed ID: 30683103
    [Abstract] [Full Text] [Related]

  • 40. After their wives have delivered, a lot of men like going out: Perceptions of HIV transmission risk and support for HIV prevention methods during breastfeeding in sub-Saharan Africa.
    Flax VL, Hawley I, Ryan J, Chitukuta M, Mathebula F, Nakalega R, Seyama L, Taulo F, van der Straten A, MTN-041/MAMMA Study Team.
    Matern Child Nutr; 2021 Apr 25; 17(2):e13120. PubMed ID: 33325126
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.